SecSonar.com

STAAR Surgical Company (STAA)

STAAR Surgical Company at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

STAAR Surgical Company (STAA) is a Medical - Instruments & Supplies company based in US with a market capitalization of $1.5B. Revenue declined 23.7% year-over-year and free cash flow was negative at -$40.1M. This page tracks STAA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.16K employees · IPO Feb 24, 1992

Valuation

Valuation & price

$32.07 · as of May 17, 2026 · -3.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.31

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$33.05$24.57$16.10Jul 25Dec 25Jul 26Jul 7, 25$16.61Jul 9, 25$17.14Jul 11, 25$17.38Jul 15, 25$16.86Jul 17, 25$17.27Jul 21, 25$17.76Jul 23, 25$19.29Jul 25, 25$19.20Jul 29, 25$18.58Jul 31, 25$17.92Aug 4, 25$18.49Aug 6, 25$26.90Aug 11, 25$27.30Aug 13, 25$28.21Aug 15, 25$28.37Aug 19, 25$27.96Aug 21, 25$27.77Aug 25, 25$27.49Aug 27, 25$27.51Aug 29, 25$27.36Sep 3, 25$27.32Sep 5, 25$27.94Sep 9, 25$27.68Sep 11, 25$28.08Sep 16, 25$27.23Sep 18, 25$27.16Sep 22, 25$26.86Sep 24, 25$26.77Sep 26, 25$26.80Sep 30, 25$26.87Oct 2, 25$27.42Oct 6, 25$26.83Oct 8, 25$26.50Oct 10, 25$26.68Oct 14, 25$27.10Oct 16, 25$24.26Oct 21, 25$26.69Oct 23, 25$26.96Oct 27, 25$27.78Oct 29, 25$26.59Oct 31, 25$25.87Nov 4, 25$25.28Nov 6, 25$26.63Nov 10, 25$27.41Nov 12, 25$25.85Nov 14, 25$26.32Nov 18, 25$25.67Nov 20, 25$27.35Nov 25, 25$26.21Nov 28, 25$26.54Dec 2, 25$25.92Dec 4, 25$26.60Dec 8, 25$23.54Dec 10, 25$23.99Dec 12, 25$24.13Dec 16, 25$24.80Dec 18, 25$24.02Dec 22, 25$24.20Dec 24, 25$23.63Dec 29, 25$23.38Jan 2, 26$23.60Jan 6, 26$22.29Jan 8, 26$22.50Jan 12, 26$22.01Jan 14, 26$21.82Jan 16, 26$20.97Jan 21, 26$20.61Jan 23, 26$19.14Jan 27, 26$19.04Jan 29, 26$18.94Feb 2, 26$18.04Feb 4, 26$17.54Feb 9, 26$17.41Feb 11, 26$17.25Feb 13, 26$16.10Feb 18, 26$17.56Feb 20, 26$17.76Feb 24, 26$19.75Feb 26, 26$20.32Mar 2, 26$19.05Mar 4, 26$19.22Mar 6, 26$18.46Mar 10, 26$17.23Mar 12, 26$18.39Mar 17, 26$17.85Mar 19, 26$17.47Mar 23, 26$18.51Mar 25, 26$19.19Mar 27, 26$17.89Mar 31, 26$18.70Apr 2, 26$20.21Apr 7, 26$21.09Apr 9, 26$25.21Apr 13, 26$26.84Apr 15, 26$24.73Apr 17, 26$25.08Apr 22, 26$24.80Apr 24, 26$25.67Apr 28, 26$26.70Apr 30, 26$26.36May 4, 26$27.29May 6, 26$27.75May 8, 26$26.69May 12, 26$28.18May 14, 26$32.01May 18, 26$32.31May 20, 26$33.05May 22, 26$32.47May 28, 26$29.08Jun 1, 26$29.55Jun 3, 26$28.26Jun 5, 26$29.99Jun 9, 26$29.87Jun 11, 26$28.90Jun 15, 26$28.37Jun 17, 26$29.22Jun 22, 26$28.83Jun 24, 26$28.92Jun 26, 26$29.29Jul 2, 26$27.79
$16.1052-week range$33.34
Loading valuation history…

Fundamentals

Key fundamentals

$1.5B

Market cap

-23.7%

Revenue growth (YoY)

76.2%

Gross margin

-$40.1M

Free cash flow (USD)

-$149.2M

Net debt

Net cash position

0.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2026

FY 2016$82.4MFY 2017$90.6MFY 2018$124.0MFY 2020$150.2MFY 2021$163.5MFY 2022$284.4MFY 2023$322.4MFY 2024$313.9MFY 2026$239.4M
$82.4M$239.4M

Free cash flow by year

2016 → 2026

FY 2016$-2.2MFY 2017$1.8MFY 2018$10.5MFY 2020$15.6MFY 2021$12.5MFY 2022$17.6MFY 2023$-3.6MFY 2024$-7.7MFY 2026$-40.0M
-$2.2M-$40.1M

Gross margin by year

2021 → 2026

FY 202172.4%FY 202278.5%FY 202378.4%FY 202476.3%FY 202676.2%
72.4%76.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • 8-K eventExecutive Compensation IncreaseJun 9, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventPreliminary Financial ResultsApr 8, 2026Filing

Questions

Frequently asked questions

What is STAAR Surgical Company's market cap?

STAAR Surgical Company (STAA) has a market capitalization of $1.5B.

What is STAA's P/E ratio?

A meaningful P/E ratio is not available for STAA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is STAA's price-to-book (P/B) ratio?

STAA trades at 4.31 times book value per share.

Are insiders buying STAA stock?

SEC Form 4 filings show no open-market insider buys at STAAR Surgical Company in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

NNNN

Anbio Biotechnology Class A Ordinary Shares

$1.5B

ATRC

AtriCure, Inc.

$1.4B

KMTS

Kestra Medical Technologies, Ltd.

$1.2B

PLSE

Pulse Biosciences, Inc.

$1.8B

AZTA

Azenta, Inc.

$1.1B

NVCR

NovoCure Limited

$2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.